Population pharmacokinetics of ciprofloxacin in patients with liver impairments analyzed by NPEM2 algorithm - A retrospective study

International Journal of Clinical Pharmacology and Therapeutics

Volumn 36, Issue 7, 1998, Pages 376-382

  Terziivanov, D ^a   Atanasova, I ^b   Dimitrova, V ^a  

^a UNIVERSITY HOSPITAL ALEXANDROVSKA   (Bulgaria)

^b Sopharma Pharmaceuticals   (Bulgaria)

Author keywords

Ciprofloxacin; Cirrhotic patients; NPEM2 algorithm; Population modelling; Random sampling

Indexed keywords

CIPROFLOXACIN; CREATININE;

ACCURACY; ALGORITHM; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; DATA ANALYSIS; DRUG ELIMINATION; FEMALE; HUMAN; KIDNEY CLEARANCE; LIVER DISEASE; MALE; ORAL DRUG ADMINISTRATION; POPULATION MODEL; RETROSPECTIVE STUDY; VALIDATION PROCESS;

ADMINISTRATION, ORAL; ALGORITHMS; ANTI-INFECTIVE AGENTS; BAYES THEOREM; BIAS (EPIDEMIOLOGY); CIPROFLOXACIN; FEMALE; HUMANS; LIVER CIRRHOSIS; MALE; MODELS, BIOLOGICAL; PREDICTIVE VALUE OF TESTS; RANDOMIZED CONTROLLED TRIALS; RETROSPECTIVE STUDIES;

EID: 0031878478     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. D'Argenio DZ 1981 Optimal sampling times for pharmacokinetic experiments. J Pharmacokinet Biopharm 9: 739-756
2. D'Argenio DZ, Schumitzky A 1979 A program package for stimulation and parameter estimation in pharmacokinetic systems. Comput Prog Biomed 9: 115-134
3. Dodge WF, Jelliffe RW, Richardson J, Bellanger RA, Hokanson JA, Snodgrass WR 1993 Population pharmacokinetic models: Measures of central tendency. Drug Invest 5: 206-211
4. Efron B 1979 Bootstrap methods: another look at the jackknife. Ann Stat 7: 1-26
5. Ette EI 1997 Stability and performance of a population pharmacokinetic model. J Clin Pharmacol 37: 486-495
6. Forrest A, Ballow CH, Nix DE, Birmingham MC, Shentag JJ 1993 Development of a population pharmacokinetic model and optimal sampling strategies for intravenous ciprofloxacin. Antimicrob Agents Chemother 37: 1065-1072
7. Gasser TC, Ebert SC, Praversen PH, Madsen P 1987 Ciprofloxacin pharmacokinetic in patients with normal and impaired renal function. Antimicrob Agents Chemother 31: 709-712
8. Jelliffe RW 1967 A mathematic analysis of digitalis kinetics in patients with normal and reduced renal function. Math Biosci 1: 305-325, 1967
9. Jelliffe RW 1986 Clinical applications of pharmacokinetics and control theory: Planning, monitoring and adjusting dosage regimens of aminoglycosides, lidocaine, digitoxin and digoxin. In: Maronde R (ed) Selected topics in clinical pharmacology and therapeutics. Springer, New York, pp 27-82
10. Jelliffe RW, Schumitzky A, Van Guilder M 1995 User manual for version 10.6. of the USC*PACK collection of PC programs. Laboratory of Applied Pharmacokinetics. University of Southern California, School of Medicine, Los Angeles
11. Ludden TM 1988 Population pharmacokinetics. J Clin Pharmcol 28: 1059-1063
12. Picard RR, Berk KN 1990 Data splitting. Am Stat 44: 140-147
13. Schumitzky A 1991 Nonparametric EM algorithms for estimating prior distributions. Appl Math Comput 45: 143-157
14. Sheiner LB, Rosenberg B, Marathe W 1977 Estimation of population characteristics of pharmacokinetic parameters from routine clinical data. J Pharmacokinet Biopharm 5: 445-479
15. Staneva M, Atanasova I, Markova B, Terziivanov D 1994 Pharmacokinetic and pharmacodynamic approach for comparing two therapeutic regimens using amikacin. Antimicrob Agent Chemother 38: 981-985
16. Terziivanov D, Scholl H 1990 Ciprofloxacin kinetics in patients with liver impairment. In: Lode H (ed) Ciprofloxacin in clinical practice: New light on established and emerging uses. Schwer Verlag, Stuttgart, pp 73-80